Baby blood test may predict teen health risks
NCT ID NCT07181733
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether a heart protein called BNP, measured in infancy and again in adolescence, can help identify teens at risk for metabolic syndrome—a cluster of conditions like obesity, high blood pressure, and diabetes. Researchers are following 70 teens who were part of a newborn study years ago. The goal is to find an early warning sign so that at-risk children can get help sooner.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to identify teenagers at risk for metabolic syndrome early, allowing for preventive measures.
- What could go wrong
- This is a small, observational study with only 70 participants. It does not test a treatment, and the link between BNP and metabolic syndrome is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2024
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients whose BNP concentration and echocardiographic parameters was analysed during their first month of life (2009-11) of life at Fondazione IRCCS Policlinico San Matteo
- Ages
-
13 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * adolescents whose BNP concentration and echocardiographic parameters analysed during their first month of life (2009-11)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
U.O.S. Cardiologia Pediatrica
RECRUITINGPavia, pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Can a weekly weight drug quiet gout attacks?
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
- Can tailoring bypass length improve weight loss surgery results?
- Can AI predict your lifespan from a short video?